Contact:
|
Marissa Vidaurri
|
Head of Investor Relations
|
|
(512) 683-5215
|
• |
Record GAAP revenue for a second quarter of $347 million, up 15 percent year over year
|
• |
Record orders for a second quarter up 33 percent year over year
|
• |
Strong GAAP operating income of $25 million, up 50 percent year over year
|
• |
Record non-GAAP operating income for a second quarter of $60 million, up 38 percent year over year
|
• |
Strong diluted GAAP EPS of $0.13 and record diluted non-GAAP EPS for a second quarter of $0.35
|
• |
Cash and short-term investments of $265 million as of June 30, 2021
|
• |
Record GAAP revenue for a first half of $682 million, up 12 percent year over year
|
• |
Strong GAAP operating income of $34 million
|
• |
Record non-GAAP operating income for a first half of $111 million
|
• |
Strong diluted GAAP EPS of $0.16 and record diluted non-GAAP EPS for a first half of $0.67
|
• |
Q3 GAAP revenue to be in the range of $355 million to $385 million, up 20 percent year over year at the midpoint
|
• |
GAAP diluted EPS to be in the range of $0.10 to $0.24 for Q3, up 21 cents year over year at the midpoint
|
• |
Non-GAAP diluted EPS expected to be in the range of $0.31 to $0.45, up 65 percent year over year at the midpoint
|
National Instruments
|
||||||
Condensed Consolidated Balance Sheets
|
||||||
(in thousands)
|
||||||
|
June 30,
|
December 31,
|
||||
|
2021
|
2020
|
||||
|
(unaudited)
|
|
||||
Assets
|
|
|
||||
Cash and cash equivalents
|
$
|
250,421
|
$
|
260,232
|
||
Short-term investments
|
14,110
|
59,923
|
||||
Accounts receivable, net
|
258,641
|
266,869
|
||||
Inventories, net
|
211,023
|
194,012
|
||||
Prepaid expenses and other current assets
|
80,121
|
68,470
|
||||
Total current assets
|
814,316
|
849,506
|
||||
Property and equipment, net
|
250,761
|
254,399
|
||||
Goodwill
|
483,136
|
467,547
|
||||
Intangible assets, net
|
149,126
|
172,719
|
||||
Operating lease right-of-use assets
|
57,812
|
67,674
|
||||
Other long-term assets
|
76,878
|
72,643
|
||||
Total assets
|
$
|
1,832,029
|
$
|
1,884,488
|
||
|
||||||
Liabilities and Stockholders' Equity
|
||||||
Accounts payable and accrued expenses
|
$
|
56,477
|
$
|
51,124
|
||
Accrued compensation
|
68,932
|
87,068
|
||||
Deferred revenue - current
|
125,986
|
132,151
|
||||
Operating lease liabilities - current
|
13,389
|
15,801
|
||||
Other taxes payable
|
39,339
|
48,129
|
||||
Debt, current
|
—
|
5,000
|
||||
Other current liabilities
|
26,854
|
42,578
|
||||
Total current liabilities
|
330,977
|
381,851
|
||||
Deferred income taxes
|
28,359
|
25,288
|
||||
Income tax payable - non-current
|
54,195
|
61,623
|
||||
Deferred revenue - non-current
|
34,624
|
36,335
|
||||
Operating lease liabilities - non-current
|
29,512
|
35,854
|
||||
Debt, noncurrent
|
100,000
|
92,036
|
||||
Other long-term liabilities
|
18,710
|
26,630
|
||||
Total liabilities
|
$
|
596,377
|
$
|
659,617
|
||
Stockholders' equity:
|
||||||
Common stock
|
1,330
|
1,312
|
||||
Additional paid-in capital
|
1,087,622
|
1,033,284
|
||||
Retained earnings
|
161,475
|
211,101
|
||||
Accumulated other comprehensive loss
|
(14,775)
|
(20,826)
|
||||
Total stockholders' equity
|
1,235,652
|
1,224,871
|
||||
Total liabilities and stockholders' equity
|
$
|
1,832,029
|
$
|
1,884,488
|
National Instruments
|
||||||||||||
Condensed Consolidated Statements of Income
|
||||||||||||
(in thousands, except per share data, unaudited)
|
||||||||||||
|
|
|
||||||||||
|
Three Months Ended
|
Six Months Ended
|
||||||||||
|
June 30,
|
June 30,
|
||||||||||
|
2021
|
2020
|
2021
|
2020
|
||||||||
|
||||||||||||
Net sales:
|
||||||||||||
Product
|
$
|
306,490
|
$
|
266,261
|
$
|
601,583
|
$
|
540,239
|
||||
Software maintenance
|
40,206
|
35,068
|
80,295
|
70,470
|
||||||||
Total net sales
|
346,696
|
301,329
|
681,878
|
610,709
|
||||||||
|
|
|
||||||||||
Cost of sales:
|
|
|
||||||||||
Product
|
95,722
|
83,795
|
187,379
|
165,866
|
||||||||
Software maintenance
|
3,516
|
2,106
|
7,273
|
3,796
|
||||||||
Total cost of sales
|
99,238
|
85,901
|
194,652
|
169,662
|
||||||||
|
|
|
||||||||||
Gross profit
|
247,458
|
215,428
|
487,226
|
441,047
|
||||||||
|
71.4%
|
71.5%
|
71.5%
|
72.2%
|
||||||||
Operating expenses:
|
||||||||||||
Sales and marketing
|
111,199
|
105,419
|
227,983
|
221,165
|
||||||||
Research and development
|
81,434
|
64,225
|
161,520
|
135,846
|
||||||||
General and administrative
|
30,277
|
29,369
|
63,636
|
55,549
|
||||||||
Total operating expenses
|
222,910
|
199,013
|
453,139
|
412,560
|
||||||||
Gain on sale of business/assets
|
—
|
—
|
—
|
159,753
|
||||||||
Operating income
|
24,548
|
16,415
|
34,087
|
188,240
|
||||||||
Other expense
|
(2,963)
|
(1,143)
|
(8,031)
|
(583)
|
||||||||
Income before income taxes
|
21,585
|
15,272
|
26,056
|
187,657
|
||||||||
Provision for income taxes
|
4,279
|
4,383
|
4,254
|
44,113
|
||||||||
Net income
|
$
|
17,306
|
$
|
10,889
|
$
|
21,802
|
$
|
143,544
|
||||
|
||||||||||||
Basic earnings per share
|
$
|
0.13
|
$
|
0.08
|
$
|
0.17
|
$
|
1.10
|
||||
Diluted earnings per share
|
$
|
0.13
|
$
|
0.08
|
$
|
0.16
|
$
|
1.09
|
||||
|
||||||||||||
Weighted average shares outstanding -
|
||||||||||||
Basic
|
132,498
|
131,014
|
131,996
|
130,813
|
||||||||
Diluted
|
133,539
|
131,602
|
133,157
|
131,499
|
||||||||
|
||||||||||||
Dividends declared per share
|
$
|
0.27
|
$
|
0.26
|
$
|
0.54
|
$
|
0.52
|
Condensed Consolidated Statements of Cash Flows
|
||||||
(in thousands, unaudited)
|
||||||
Six Months Ended June 30,
|
||||||
2021
|
2020
|
|||||
Cash flow from operating activities:
|
||||||
Net income
|
$
|
21,802
|
$
|
143,544
|
||
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|||||
Disposal gains on sale of business/asset
|
—
|
(159,753)
|
||||
Depreciation and amortization
|
50,024
|
38,341
|
||||
Stock-based compensation
|
37,208
|
27,335
|
||||
Loss from equity-method investees
|
5,360
|
1,932
|
||||
Deferred income taxes
|
1,301
|
2,711
|
||||
Net change in operating assets and liabilities
|
(63,372)
|
47,388
|
||||
Net cash provided by operating activities
|
52,323
|
101,498
|
||||
Cash flow from investing activities:
|
||||||
Acquisitions, net of cash received
|
(19,784)
|
—
|
||||
Capital expenditures
|
(17,411)
|
(25,362)
|
||||
Proceeds from sale of assets/business, net of cash divested
|
—
|
160,266
|
||||
Capitalization of internally developed software
|
(721)
|
(3,108)
|
||||
Additions to other intangibles
|
(1,519)
|
(630)
|
||||
Payments to acquire equity-method investments
|
(12,551)
|
—
|
||||
Purchases of short-term investments
|
—
|
(206,330)
|
||||
Sales and maturities of short-term investments
|
45,671
|
306,955
|
||||
Net cash (used in) provided by investing activities
|
(6,315)
|
231,791
|
||||
Cash flow from financing activities:
|
||||||
Proceeds from revolving loan facility
|
100,000
|
20,000
|
||||
Proceeds from term loan
|
—
|
70,000
|
||||
Payments on term loan
|
(98,750)
|
—
|
||||
Debt issuance costs
|
(1,993)
|
(1,480)
|
||||
Proceeds from issuance of common stock
|
17,239
|
17,252
|
||||
Repurchase of common stock
|
—
|
(23,680)
|
||||
Dividends paid
|
(71,428)
|
(68,156)
|
||||
Net cash (used in) provided by financing activities
|
(54,932)
|
13,936
|
||||
|
|
|||||
Impact of changes in exchange rates on cash
|
(887)
|
(636)
|
||||
Net change in cash and cash equivalents
|
(9,811)
|
346,589
|
||||
Cash and cash equivalents at beginning of period
|
260,232
|
194,616
|
||||
Cash and cash equivalents at end of period
|
$
|
250,421
|
$
|
541,205
|
The following tables provide details with respect to the amount of GAAP charges related to stock-based
compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges,
gains on sale of business/assets, and other that were recorded in the line items indicated below (unaudited) (in thousands)
|
||||||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||
June 30,
|
June 30,
|
|||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||
Stock-based compensation
|
||||||||||||
Cost of sales
|
$
|
1,191
|
$
|
932
|
$
|
2,305
|
$
|
1,736
|
||||
Sales and marketing
|
6,922
|
6,467
|
12,617
|
11,642
|
||||||||
Research and development
|
6,180
|
4,428
|
11,893
|
7,947
|
||||||||
General and administrative
|
5,854
|
3,404
|
10,520
|
6,008
|
||||||||
Provision for income taxes
|
(3,916)
|
(2,905)
|
(7,241)
|
(4,406)
|
||||||||
Total
|
$
|
16,231
|
$
|
12,326
|
$
|
30,094
|
$
|
22,927
|
||||
Amortization of acquisition-related intangibles and fair value adjustments
|
||||||||||||
Net sales
|
$
|
738
|
$
|
—
|
$
|
1,551
|
$
|
—
|
||||
Cost of sales
|
4,226
|
635
|
8,497
|
1,381
|
||||||||
Sales and marketing
|
2,357
|
480
|
4,528
|
966
|
||||||||
Research and development
|
—
|
28
|
—
|
55
|
||||||||
Other expense
|
554
|
117
|
948
|
241
|
||||||||
Provision for income taxes
|
(979)
|
(133)
|
(1,969)
|
(290)
|
||||||||
Total
|
$
|
6,896
|
$
|
1,127
|
$
|
13,555
|
$
|
2,353
|
||||
Acquisition transaction and integration costs, restructuring charges, and other(1)(2)
|
||||||||||||
Cost of sales
|
$
|
(118)
|
$
|
—
|
$
|
(43)
|
$
|
20
|
||||
Sales and marketing
|
839
|
1,239
|
5,487
|
7,612
|
||||||||
Research and development
|
548
|
147
|
1,036
|
4,816
|
||||||||
General and administrative
|
873
|
3,399
|
6,539
|
2,385
|
||||||||
Gain on sale of business/assets
|
—
|
—
|
—
|
(159,753)
|
||||||||
Other expense
|
280
|
—
|
4,006
|
128
|
||||||||
Provision for income taxes
|
(578)
|
(78)
|
(3,463)
|
34,676
|
||||||||
Total
|
$
|
1,844
|
$
|
4,707
|
$
|
13,562
|
$
|
(110,116)
|
||||
(1): During the first quarter of 2020, we recognized a gain of approximately $160 million related to the divestiture of AWR,
presented within "Gain on sale of business/assets".
|
||||||||||||
(2): During the first quarter of 2021, we recognized a $3.5 million impairment loss related to one of our equity-method
investments.
|
||||||||||||
Capitalization and amortization of internally developed software costs
|
||||||||||||
Cost of sales
|
$
|
6,227
|
$
|
7,144
|
$
|
13,101
|
$
|
14,226
|
||||
Research and development
|
(495)
|
(1,181)
|
(721)
|
(3,095)
|
||||||||
Provision for income taxes
|
(1,204)
|
(1,252)
|
(2,600)
|
(2,337)
|
||||||||
Total
|
$
|
4,528
|
$
|
4,711
|
$
|
9,780
|
$
|
8,794
|
National Instruments
|
||||||||||||
Reconciliation of GAAP to Non-GAAP Measures
|
||||||||||||
(in thousands, unaudited)
|
||||||||||||
|
|
|
|
|
||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||
June 30,
|
June 30,
|
|||||||||||
2021
|
2020
|
2021
|
2020
|
|||||||||
Reconciliation of Net sales to Non-GAAP Net sales
|
||||||||||||
Net sales, as reported
|
$
|
346,696
|
301,329
|
681,878
|
$
|
610,709
|
||||||
plus: Impact of acquisition-related fair value adjustments
|
738
|
—
|
1,551
|
—
|
||||||||
Non-GAAP net sales
|
$
|
347,434
|
301,329
|
683,429
|
$
|
610,709
|
||||||
Reconciliation of Gross Profit to Non-GAAP Gross Profit
|
||||||||||||
Gross profit, as reported
|
$
|
247,458
|
$
|
215,428
|
$
|
487,226
|
$
|
441,047
|
||||
Stock-based compensation
|
1,191
|
932
|
2,305
|
1,736
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
4,964
|
635
|
10,048
|
1,381
|
||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
(118)
|
—
|
(43)
|
20
|
||||||||
Amortization of internally developed software costs
|
6,227
|
7,144
|
13,101
|
14,226
|
||||||||
Non-GAAP gross profit
|
$
|
259,722
|
$
|
224,139
|
$
|
512,637
|
$
|
458,410
|
||||
Non-GAAP gross margin
|
74.8%
|
74.4%
|
75.0%
|
75.1%
|
||||||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
|
||||||||||||
Operating expenses, as reported
|
$
|
222,910
|
$
|
199,013
|
$
|
453,139
|
$
|
412,560
|
||||
Stock-based compensation
|
(18,956)
|
(14,299)
|
(35,030)
|
(25,597)
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
(2,357)
|
(508)
|
(4,528)
|
(1,021)
|
||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
(2,260)
|
(4,785)
|
(13,062)
|
(14,813)
|
||||||||
Capitalization of internally developed software costs
|
495
|
1,181
|
721
|
3,095
|
||||||||
Non-GAAP operating expenses
|
$
|
199,832
|
$
|
180,602
|
$
|
401,240
|
$
|
374,224
|
||||
Reconciliation of Operating Income to Non-GAAP Operating Income
|
||||||||||||
Operating income, as reported
|
$
|
24,548
|
$
|
16,415
|
$
|
34,087
|
$
|
188,240
|
||||
Stock-based compensation
|
20,147
|
15,231
|
37,335
|
27,333
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
7,321
|
1,143
|
14,576
|
2,402
|
||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
2,142
|
4,785
|
13,019
|
14,833
|
||||||||
Net amortization of internally developed software costs
|
5,732
|
5,963
|
12,380
|
11,131
|
||||||||
Gain on sale of business/assets
|
—
|
—
|
—
|
(159,753)
|
||||||||
Non-GAAP operating income
|
$
|
59,890
|
$
|
43,537
|
$
|
111,397
|
$
|
84,186
|
||||
Non-GAAP operating margin
|
17.2%
|
14.4%
|
16.3%
|
13.8%
|
||||||||
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(1)
|
||||||||||||
Provision for income taxes, as reported
|
$
|
4,279
|
$
|
4,383
|
$
|
4,254
|
$
|
44,113
|
||||
Stock-based compensation
|
3,916
|
2,905
|
7,241
|
4,406
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
979
|
133
|
1,969
|
290
|
||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
578
|
466
|
3,463
|
2,083
|
||||||||
Net amortization of internally developed software costs
|
1,204
|
1,252
|
2,600
|
2,337
|
||||||||
Gain on sale of business/assets
|
—
|
(388)
|
—
|
(36,759)
|
||||||||
Non-GAAP provision for income taxes(1)
|
$
|
10,956
|
$
|
8,751
|
$
|
19,527
|
$
|
16,470
|
||||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates
applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
|
Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income, Non-GAAP Diluted EPS, and
EBITDA
|
||||||||||||
(in thousands, except per share data, unaudited)
|
||||||||||||
|
|
|
|
|
||||||||
|
Three Months Ended
|
Six Months Ended
|
||||||||||
|
June 30,
|
June 30,
|
||||||||||
|
2021
|
2020
|
2021
|
2020
|
||||||||
|
|
|
|
|||||||||
Net income, as reported
|
$
|
17,306
|
$
|
10,889
|
$
|
21,802
|
$
|
143,544
|
||||
Adjustments to reconcile net income to non-GAAP net income:
|
||||||||||||
Stock-based compensation
|
20,147
|
15,231
|
37,335
|
27,333
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
7,875
|
1,260
|
15,524
|
2,643
|
||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
2,422
|
4,785
|
17,025
|
14,981
|
||||||||
Net amortization of internally developed software costs
|
5,732
|
5,963
|
12,380
|
11,131
|
||||||||
Gain on sale of business/assets
|
—
|
—
|
—
|
(159,753)
|
||||||||
Income tax effects and adjustments(1)
|
(6,677)
|
(4,368)
|
(15,273)
|
27,643
|
||||||||
Non-GAAP net income
|
$
|
46,805
|
$
|
33,760
|
$
|
88,793
|
$
|
67,522
|
||||
Non-GAAP net margin
|
13.5%
|
11.2%
|
13.0%
|
11.1%
|
||||||||
Diluted EPS, as reported
|
$
|
0.13
|
$
|
0.08
|
$
|
0.16
|
$
|
1.09
|
||||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
|
||||||||||||
Stock-based compensation
|
0.15
|
0.12
|
0.28
|
0.21
|
||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
0.06
|
0.01
|
0.12
|
0.02
|
||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
0.02
|
0.04
|
0.13
|
0.11
|
||||||||
Net amortization of internally developed software costs
|
0.04
|
0.05
|
0.09
|
0.08
|
||||||||
Gain on sale of business/assets
|
—
|
—
|
—
|
(1.21)
|
||||||||
Income tax effects and adjustments(1)
|
(0.05)
|
(0.04)
|
(0.11)
|
0.21
|
||||||||
Non-GAAP diluted EPS
|
$
|
0.35
|
$
|
0.26
|
$
|
0.67
|
$
|
0.51
|
||||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax
rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
|
June 30,
|
|
June 30,
|
||||||||||||
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
||||||||
Net income, as reported
|
$
|
17,306
|
$
|
10,889
|
$
|
21,802
|
$
|
143,544
|
||||||||
Adjustments to reconcile net income to EBITDA:
|
|
|
|
|
|
|
|
|
||||||||
Interest expense (income), net
|
1,110
|
(945)
|
1,653
|
(3,168)
|
||||||||||||
Tax expense
|
4,279
|
4,383
|
4,254
|
44,113
|
||||||||||||
Depreciation and amortization
|
|
26,152
|
|
19,076
|
|
50,024
|
38,341
|
|||||||||
EBITDA
|
$
|
48,847
|
$
|
33,403
|
$
|
77,733
|
$
|
222,830
|
||||||||
Weighted average shares outstanding - Diluted
|
|
133,539
|
131,602
|
133,157
|
131,499
|
|||||||||||
|
|
|
|
|
|
|
|
Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS Guidance
|
|||||||
(unaudited)
|
|||||||
|
Three Months Ended
|
||||||
|
September 30, 2021
|
||||||
|
|
|
|||||
|
Low
|
High
|
|||||
GAAP Diluted EPS, guidance
|
$
|
0.10
|
$
|
0.24
|
|||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
|
|
||||||
Stock-based compensation
|
0.14
|
0.14
|
|||||
Amortization of acquisition-related intangibles and fair value adjustments
|
0.06
|
0.06
|
|||||
Acquisition transaction and integration costs, restructuring charges, and other
|
0.01
|
0.01
|
|||||
Net amortization of software development costs
|
0.04
|
0.04
|
|||||
Income tax effects and adjustments(1)
|
(0.04)
|
(0.04)
|
|||||
Non-GAAP Diluted EPS, guidance
|
$
|
0.31
|
$
|
0.45
|
|||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax
rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
|